Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$68.7M
6 rounds on record
Latest round
$24.5M
Venture round · May 2026 · 4 mo ago
Team
68
US Form 5500 (plan participants) · Dec 2025 · +33% in a year
Backers
1
USVP
The money's age
Fresh money
4 months since the last round · not hiring
Momentum
20/100
fresh money
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2026 $24.5M — SEC Form D
Venture round Jan 2024 $28.7M — SEC Form D
Debt Financing Apr 2023 $7.2M — SEC Form D
Venture round Jun 2021 $9.5M — SEC Form D
Venture round Jul 2017 $3M — SEC Form D
Venture round Jul 2017 $3M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Cagent Vascular, LLC sec
Founders and leadersfrom filings, registers and the company's site
Carol BurnsExecutive Officer, DirectorSEC Form D
Dennis McGrathExecutive OfficerSEC Form D
Brian WalshExecutive Officer, DirectorSEC Form D
Aaron GreenExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Neuros MedicalVenture round $56M · 14 mo ago
Who We Are Giving patients the ability to gain power over pain About Neuros There are nearly two million amputees in the U.S., with 185,000…
Cincinnati-based surgical procedure company focused on innovative development, commercialization of medical devices for treatment of…
LuminopiaVenture round $15.8M · 3 yr ago • Founded 2015 • 51-200 employees
Luminopia is the first FDA-cleared binocular therapy for amblyopia.
Nalu Medical delivers an innovative, evidence-based therapy to treat chronic nerve pain safely and effectively.
Luminate Medical51-200 employees • 8 roles
We deliver cutting edge cancer care in the home - reducing costs for patients, providers, and payers.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice.

Overview

Cagent Vascular pioneers Serration Remodeling Therapy (SRT) creating controlled lines of weakness to release the internal elastic lamina, reducing recoil and increasing luminal gain in PAD angioplasty.

People

Carol Burns
Executive Officer, Director
Dennis McGrath
Executive Officer
Brian Walsh
Executive Officer, Director
Aaron Green
Executive Officer
Peter Schneider
Director
Robert Giasolli
Director
Fred Lampropoulos
Director
Mike Markert
Director
Marc-Andre Marcotte
Director
Greg Fredde
Director
Casey Tansey
Director
Bruce Blumfield
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Wayne United States
HQ
10-50 est. staff

Financials

Total raised
$76M
Latest round
Venture - Series Unknown
Funding rounds
6
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $24.5M Details
Venture - Series Unknown 2024 $28.7M Details
Debt Financing 2023 $7.2M Details
Venture - Series Unknown 2021 $9.5M Details
Venture - Series Unknown 2017 $3M Details
Venture - Series Unknown 2017 $3M Details